Clinical trial data platform
ClinicalTrials.gov (global)
594,309
Studies (totalCount)
Ongoing trials by phase
1,850
Early Phase 1 (preclinical)
11,125
Phase 1
18,768
Phase 2
7,990
Phase 3
Completed trials
324,591
Completed (overall status)
Last synced: 2026-07-17 15:49:12 (UTC server time).
Recently FDA-approved drugs
LYTENAVA
- Ingredient
- BEVACIZUMAB-VIKG
- Approval
- 2026-07-24
- Application
- BLA761320
- Sponsor
- OUTLOOK THERAPEUTICS, INC.
XOCOVA
- Ingredient
- ENSITRELVIR
- Approval
- 2026-05-29
- Application
- NDA220442
- Sponsor
- SHIONOGI
CIPEPOFOL
- Ingredient
- CIPEPOFOL
- Approval
- 2026-05-29
- Application
- NDA220482
- Sponsor
- HAISCO PHARMACEUTICAL GROUP CO LTD
BEQALZI
- Ingredient
- SONROTOCLAX
- Approval
- 2026-05-13
- Application
- NDA220711
- Sponsor
- BEONE MEDICINES USA
YUVIWEL
- Ingredient
- NAVEPEGRITIDE
- Approval
- 2026-02-27
- Application
- NDA219164
- Sponsor
- ASCENDIS
JASCAYD
- Ingredient
- NERANDOMILAST
- Approval
- 2025-12-19
- Application
- NDA220449
- Sponsor
- BOEHRINGER INGELHEIM
Recently completed Phase 3 trials
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
- Topic
- Generalized Myasthenia Gravis
- Start
- 2019-12-23
- Completion
- 2026-07-31
- Sponsor
- UCB Biopharma SRL
A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)
- Topic
- Muscular Atrophy, Spinal
- Start
- 2021-04-19
- Completion
- 2026-07-30
- Sponsor
- Biogen
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
- Topic
- Chronic Hepatitis B With Hepatic Fibrosis
- Start
- 2026-03-16
- Completion
- 2026-07-28
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
The Role of SGLT2i in Management of Moderate AS
- Topic
- Moderate Aortic Valve Stenosis
- Start
- 2024-05-30
- Completion
- 2026-07-24
- Sponsor
- University of East Anglia
A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19
- Topic
- COVID-19
- Start
- 2025-10-30
- Completion
- 2026-07-24
- Sponsor
- BioNTech SE
Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
- Topic
- OAG - Open-Angle Glaucoma
- Start
- 2026-03-18
- Completion
- 2026-07-22
- Sponsor
- Qlaris Bio, Inc.
ClinicalTrials.gov search results
- NCT07210515RECRUITINGINTERVENTIONALPHASE3
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) - NCT07753733RECRUITINGINTERVENTIONALNA
Flexible Nephroscopy-Assisted Single-Tract Versus Multi-Tract Percutaneous Nephrolithotomy for Complex Renal Stones - NCT06890338RECRUITINGINTERVENTIONALPHASE2
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. - NCT05864534RECRUITINGINTERVENTIONALPHASE2
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma - NCT07766291NOT_YET_RECRUITINGINTERVENTIONALNA
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep Phenotyping - NCT07553442RECRUITINGINTERVENTIONALPHASE2
A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran - NCT07764744NOT_YET_RECRUITINGINTERVENTIONALNA
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants - NCT07764887NOT_YET_RECRUITINGINTERVENTIONALNA
Impacted Tooth Management and Osteoradionecrosis Risk in NPC - NCT04858958COMPLETEDINTERVENTIONALPHASE1
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation - NCT07179380RECRUITINGINTERVENTIONALPHASE3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) - NCT07765394COMPLETEDINTERVENTIONALNA
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health - NCT07643623RECRUITINGINTERVENTIONALPHASE2, PHASE3
Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma - NCT07766057COMPLETEDOBSERVATIONAL
Early Dental Implant Installation in Regeneration Sites: a Prof of Concept Prospective Case Study - NCT06669156COMPLETEDOBSERVATIONAL
Insufficient Regional Anesthesia and Conversion to General Anesthesia for Cesarean Section A Qualitative Multicenter Study - NCT06718101ACTIVE_NOT_RECRUITINGINTERVENTIONALPHASE2
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis - NCT07071519RECRUITINGINTERVENTIONALPHASE3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis - NCT07764575NOT_YET_RECRUITINGOBSERVATIONAL
Predictors of Extubation Failure in Ventilated Neonates - NCT07530042COMPLETEDINTERVENTIONALNA
Efficacy of Electroacupuncture Combined With Auricular Acupressure for Chronic Low Back Pain. - NCT06892288ACTIVE_NOT_RECRUITINGINTERVENTIONALPHASE2, PHASE3
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG - NCT07765524NOT_YET_RECRUITINGINTERVENTIONALPHASE1, PHASE2
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
MediTrans services
Request data-backed reports, medical writing, or custom clinical intelligence deliverables.
